1995PubMedRequires access

[Transrectal hyperthermia in the treatment of benign prostatic hyperplasia].

X Wang, S. Hou, Zhu J

Open publisher page 0 citations

Abstract

A group of 53 patients with benign prostatic hyperplasia underwent transrectal hyperthermia using Prostathermer (Biodan) from September 1992 to March 1993. 41 of the 53 patients were followed up for 6 months. The subjective symptoms improved in 75.6% (31/41) of the treated patients. The mean maximum urine flow rate increased by 3.1 +/- 2.6 ml/s. The mean residual urine reduced 38.4 +/- 25.2 ml. The mean prostate volume remained almost unchanged. The results showed that transrectal hyperthermia of the prostate gland is as effective as transurethral approach for the treatment of benign prostatic hyperplasia.

About this research paper

What this paper is about

A group of 53 patients with benign prostatic hyperplasia underwent transrectal hyperthermia using Prostathermer (Biodan) from September 1992 to March 1993. 41 of the 53 patients were followed up for 6 months. The subjective symptoms improved in 75.6% (31/41) of the treated patients. The mean maximum urine flow rate increased by 3.1 +/- 2.6 ml/s. The mean residual urine reduced 38.4 +/- 25.2 ml. The mean prostate volume remained almost unchanged. The results showed that transrectal hyperthermia of the prostate gland is as effective as transurethral approach for the treatment of benign prostatic hyperplasia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A group of 53 patients with benign prostatic hyperplasia underwent transrectal hyperthermia using Prostathermer (Biodan) from September 1992 to March 1993. 41 of the 53 patients were followed up for 6 months. The subjective symptoms improved in 75.6% (31/41) of the treated patients. The mean maximum urine flow rate increased by 3.1 +/- 2.6 ml/s. The mean residual urine reduced 38.4 +/- 25.2 ml. The mean prostate volume remained almost unchanged. The results showed that transrectal hyperthermia of the prostate gland is as effective as transurethral approach for the treatment of benign prostatic hyperplasia.

Key concepts: Medicine, Hyperplasia, Hyperthermia, Urology, Prostate, Urine flow rate, Residual urine, Adenoma

Related papers

Back to paper searchBrowse research topicsOriginal source
[Transrectal hyperthermia in the treatment of benign prostatic hyperplasia]. — Research Paper | ScholarLens